Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

National Cancer Center Hospital East: Clinical Trials & FDA Approval Profile

National Cancer Center Hospital East (Global / Institutional) sponsors 16 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 10 active protocols (4 recruiting now), 6 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)30 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for National Cancer Center Hospital East
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)16
Active Pipeline (Recruiting Now)10 (4)
Completed vs Stopped Early6 / 0 (0.0%)
Median Closed Actual Enrollment30 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With National Cancer Center Hospital East
Hospital Research SiteLocationShared Protocols
National Cancer Center Hospital EastKashiwa, Chiba12
National Cancer Center HospitalTokyo3
Yokohama City University Medical CenterYokohama3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by National Cancer Center Hospital East
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05646511TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal CancerPhase IIIRECRUITING
NCT04288999Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal CancerPhase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the National Cancer Center Hospital East Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI